240 related articles for article (PubMed ID: 17287821)
21. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze.
Albrechet-Souza L; Borelli KG; Brandão ML
J Neurosci Methods; 2008 Mar; 169(1):109-18. PubMed ID: 18190969
[TBL] [Abstract][Full Text] [Related]
22. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
23. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
[TBL] [Abstract][Full Text] [Related]
24. In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments.
Rubino T; Viganò D; Zagato E; Sala M; Parolaro D
Synapse; 2000 Jan; 35(1):8-14. PubMed ID: 10579803
[TBL] [Abstract][Full Text] [Related]
25. THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior.
Dahlén A; Zarei M; Melgoza A; Wagle M; Guo S
Sci Rep; 2021 Aug; 11(1):15693. PubMed ID: 34344922
[TBL] [Abstract][Full Text] [Related]
26. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.
Haberny SL; Carr KD
Neuroscience; 2005; 132(4):1035-43. PubMed ID: 15857708
[TBL] [Abstract][Full Text] [Related]
27. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade.
Rubino T; Viganò D; Premoli F; Castiglioni C; Bianchessi S; Zippel R; Parolaro D
Mol Neurobiol; 2006 Jun; 33(3):199-213. PubMed ID: 16954596
[TBL] [Abstract][Full Text] [Related]
28. Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze.
Huang P; Liu-Chen LY; Kirby LG
Neurosci Lett; 2010 May; 475(3):165-8. PubMed ID: 20363293
[TBL] [Abstract][Full Text] [Related]
29. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
[TBL] [Abstract][Full Text] [Related]
30. Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.
Polissidis A; Chouliara O; Galanopoulos A; Rentesi G; Dosi M; Hyphantis T; Marselos M; Papadopoulou-Daifoti Z; Nomikos GG; Spyraki C; Tzavara ET; Antoniou K
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1175-91. PubMed ID: 19941698
[TBL] [Abstract][Full Text] [Related]
31. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys.
McMahon LR; France CP
Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262
[TBL] [Abstract][Full Text] [Related]
32. Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats.
Braida D; Iosuè S; Pegorini S; Sala M
Eur J Pharmacol; 2004 Dec; 506(1):63-9. PubMed ID: 15588625
[TBL] [Abstract][Full Text] [Related]
33. Cocaine-induced CREB phosphorylation in nucleus accumbens of cocaine-sensitized rats is enabled by enhanced activation of extracellular signal-related kinase, but not protein kinase A.
Mattson BJ; Bossert JM; Simmons DE; Nozaki N; Nagarkar D; Kreuter JD; Hope BT
J Neurochem; 2005 Dec; 95(5):1481-94. PubMed ID: 16219028
[TBL] [Abstract][Full Text] [Related]
34. Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats.
Schramm-Sapyta NL; Cha YM; Chaudhry S; Wilson WA; Swartzwelder HS; Kuhn CM
Psychopharmacology (Berl); 2007 May; 191(4):867-77. PubMed ID: 17211649
[TBL] [Abstract][Full Text] [Related]
35. Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons.
Morera-Herreras T; Ruiz-Ortega JA; Gómez-Urquijo S; Ugedo L
Neuroscience; 2008 Feb; 151(3):817-23. PubMed ID: 18164823
[TBL] [Abstract][Full Text] [Related]
36. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
37. Chronic nicotine exposure attenuates the effects of Δ
Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
[TBL] [Abstract][Full Text] [Related]
38. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
Caberlotto L; Rimondini R; Hansson A; Eriksson S; Heilig M
Neuropsychopharmacology; 2004 Jan; 29(1):15-22. PubMed ID: 12968131
[TBL] [Abstract][Full Text] [Related]
40. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
Sink KS; Segovia KN; Sink J; Randall PA; Collins LE; Correa M; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
Eur Neuropsychopharmacol; 2010 Feb; 20(2):112-22. PubMed ID: 20015619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
